Perot Systems reorganizes, takes $48 million charge
Perot Systems, an active player on the acquisition front in healthcare last year, has announced an organizational restructuring plan that will eliminate 200 jobs worldwide and result in a $48 million nonrecurring charge. The company plans to
Perot Systems, an active player on the acquisition front in healthcare last year, has announced an organizational restructuring plan that will eliminate 200 jobs worldwide and result in a $48 million nonrecurring charge. The company plans to spread the charge over two quarters, allocating $37 million to fourth quarter 2000 (-20¢ per share) and $11 million in first quarter 2001 (-6¢ per share). As part of the reorganization, Perot Systems' marketing strategy will emphasize the three vertical channels that bring in two-thirds of its revenue: healthcare, financial services, and manufacturing. The company will also concentrate on three horizontal markets: business consulting, software engineering, and technology infrastructure services.
In moves that further increased its healthcare presence, Perot just completed two acquisitions. In December, Perot completed the purchase of Health Systems Design (a provider of healthcare payer services), and earlier this month the firm bought Covation (a managed-care services ASP).
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
